Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Balu

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
The AAPS Journal|July 17, 2013
Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspectiveAnas M Fathallah, Richard B Bankert, Sathy V Balu-Iyer
The AAPS Journal|October 3, 2007
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIIIRazvan D Miclea, Vivek S Purohit, Sathy V Balu-Iyer
Chemistry and Physics of Lipids|October 26, 2011
Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranesAaron Peng, Dipak S Pisal, Amy Doty, et al.
International Journal of Cardiology|April 1, 1983
Improved exercise performance following single daily dose of atenolol in stable anginaV Balu, A R Zaki Masud, D C Dean, et al.
Journal of Pharmaceutical Sciences|February 2, 2022
Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and LysophosphatidylserineNhan H Nguyen, Manlin Chen, Vincent Chak, et al.
Immunological Investigations|April 30, 2021
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 VaccinesKirk Hofman, Gautam N Shenoy, Vincent Chak, et al.
Pharmaceutical Research|September 3, 2011
Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in ratsLeonid Kagan, Michael R Turner, Sathy V Balu-Iyer, et al.
Immunological Investigations|March 25, 2020
Biological Function and Immunotherapy Utilizing Phosphatidylserine-based NanoparticlesFiona Y Glassman, Robert Dingman, Helena C Yau, et al.
Journal of Pharmaceutical Sciences|September 26, 2024
Immunogenicity risk assessment of empty capsids present in adeno-associated viral vectors using predictive innate immune responsesNicole Jarvi, Kirk Hofman, Aditi Venkatesh, et al.
Biochimica Et Biophysica Acta|October 16, 2007
Development and characterization of lipidic cochleate containing recombinant factor VIIIRazvan D Miclea, Prashant R Varma, Aaron Peng, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
The AAPS Journal|July 17, 2013
Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspectiveAnas M Fathallah, Richard B Bankert, Sathy V Balu-Iyer
The AAPS Journal|October 3, 2007
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIIIRazvan D Miclea, Vivek S Purohit, Sathy V Balu-Iyer
Chemistry and Physics of Lipids|October 26, 2011
Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranesAaron Peng, Dipak S Pisal, Amy Doty, et al.
International Journal of Cardiology|April 1, 1983
Improved exercise performance following single daily dose of atenolol in stable anginaV Balu, A R Zaki Masud, D C Dean, et al.
Journal of Pharmaceutical Sciences|February 2, 2022
Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and LysophosphatidylserineNhan H Nguyen, Manlin Chen, Vincent Chak, et al.
Immunological Investigations|April 30, 2021
Pharmaceutical Aspects and Clinical Evaluation of COVID-19 VaccinesKirk Hofman, Gautam N Shenoy, Vincent Chak, et al.
Pharmaceutical Research|September 3, 2011
Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in ratsLeonid Kagan, Michael R Turner, Sathy V Balu-Iyer, et al.
Immunological Investigations|March 25, 2020
Biological Function and Immunotherapy Utilizing Phosphatidylserine-based NanoparticlesFiona Y Glassman, Robert Dingman, Helena C Yau, et al.
Journal of Pharmaceutical Sciences|September 26, 2024
Immunogenicity risk assessment of empty capsids present in adeno-associated viral vectors using predictive innate immune responsesNicole Jarvi, Kirk Hofman, Aditi Venkatesh, et al.
Biochimica Et Biophysica Acta|October 16, 2007
Development and characterization of lipidic cochleate containing recombinant factor VIIIRazvan D Miclea, Prashant R Varma, Aaron Peng, et al.
Pageof 8